HGG-52. SUSTAINED RESPONSE TO CRIZOTINIB MONOTHERAPY IN AN INFANT WITH GOPC-ROS1 FUSED CONGENITAL HEMISPHERIC GLIOMA

Recent studies identified the presence of ALK/ROS/NTRK/MET alterations in a subset of infantile hemispheric gliomas. We report a case of GOPC-ROS1 fused congenital hemispheric glioma with a sustained response to crizotinib. An infant born at 28 weeks gestation was diagnosed with a large hemispheric...

Descripción completa

Detalles Bibliográficos
Autores principales: Lulla, Rishi, Svokos, Konstantina, Pelton, Kristine, Anthony, Douglas, Touat, Mehdi, Ligon, Keith L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
High Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715144/
http://dx.doi.org/10.1093/neuonc/noaa222.332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715144/
http://dx.doi.org/10.1093/neuonc/noaa222.332

Ejemplares similares